Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

The Lancet

Volumn 343, Issue 8900, 1994, Pages 769-772

  García Rodríguez, La ^a   Jick, H ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; AZAPROPAZONE; CORTICOSTEROID; DICLOFENAC; DIFLUNISAL; ETODOLAC; FENBUFEN; FENOPROFEN; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; MEFENAMIC ACID; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; SULINDAC; TENOXICAM; TIAPROFENIC ACID;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM PERFORATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; STOMACH ULCER; UNITED STATES; UPPER GASTROINTESTINAL TRACT;

EID: 0028327671     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)91843-0     Document Type: Article

References (7)

1. Non-steroidal anti-inflammatory drugs and peptic ulcers: facts and figures multiply, but do they add up?
2. The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease
3. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom
4. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom
5. Confidence intervals for interaction
6. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons